Skip to content

Effect of Pregabalin or Adductor Canal Block on Postoperative Analgesia

Effect of Pregabalin or Adductor Canal Block on Postoperative Analgesia After Arthroscopic Anterior Cruciate Ligament Reconstruction (ACL)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03530280
Enrollment
51
Registered
2018-05-21
Start date
2018-06-01
Completion date
2018-12-01
Last updated
2019-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain After Knee Arthroscopy

Keywords

pregabalin, adductor canal block, postoperative pain

Brief summary

arthroscopically Anterior Cruciate Ligament Reconstruction (ACL) under spinal anesthesia were included in this study.

Detailed description

Patients who American Society of Anesthesiologists (ASA) classification I to II scheduled to undergo arthroscopically assisted ACL reconstructions under spinal anesthesia are included in this study. The first group is administered 150 mg oral pregabalin 1 hour before surgery and the postoperative sham block was performed with an ultrasound probe. The second group is the control group; patients in this group are administered a placebo capsule 1 hour before surgery and sham block was performed with an ultrasound probe.The third group is administered a placebo capsule 1 hour before surgery and postoperative adductor canal block is performed. All patients will be received postoperative a tramadol i.v. patient control analgesia device. At the end of 24 hours, the total amount of tramadol consumed by the patient will be recorded from the patient control analgesia. NRS score, white fast track, satisfaction will be questioned.

Interventions

preoperative pregabalin and the postoperative sham block will perform.

DRUGPlacebo oral tablet

The preoperative placebo oral tablet and the postoperative sham block will perform.

DRUGadductor canal block including bupivacaine

The preoperative placebo oral tablet and adductor channel block including 10 mL of 0.25% bupivacaine with 5 μg/mL epinephrine

Sponsors

Ankara Diskapi Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients between the ages of 18 and 70 years * American Society of Anesthesiologists I or II * Scheduled to undergo knee arthroscopy

Exclusion criteria

* allergic to any medicines * History of drug or alcohol abuse, * Opioids or sedative medications * History of psychiatric conditions * Pregnant or lactating women

Design outcomes

Primary

MeasureTime frameDescription
11-point numerical rating scale (NRS)24 hours11-point numerical rating scale for pain (0='no pain' and 10='worst pain possible pain') were explained.
tramadol consumption24 hours24 hours tramadol consumption will be recorded as milligrams

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026